LAURA PENNAVARIA: Open Payments
NPI 1053324624 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 14 payments from 8 companies in 2025. Trend: 2023 $219 · 2024 $186 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $162 |
| Amgen Inc. | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
Products named: QULIPTA, OTEZLA, GEMTESA, Kerendia, VRAYLAR, Cologuard Collection Kit, TRINTELLIX, IBSRELA.
Industry payments across OR — which companies pay providers there.
